Emergent Biosolutions

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$293,800
$254,700
$300,400
$276,600
Gross Profit
171,200
-54,500
139,400
74,800
EBITDA
177,100
-216,800
65,200
-1,800
EBIT
150,700
-246,200
36,400
-32,300
Net Income
114,800
-283,100
9,000
-49,500
Net Change In Cash
293,800
254,700
300,400
276,600
Free Cash Flow
147,900
42,900
-73,400
20,700
Cash
149,900
71,000
79,000
111,700
Basic Shares
55,600
52,600
52,200
51,900

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$1,049,300
$1,120,900
$1,792,700
$1,555,400
Gross Profit
343,900
427,200
1,035,200
1,031,400
EBITDA
-505,299
-34,400
458,200
549,000
EBIT
-630,399
-166,000
331,900
434,600
Net Income
-760,500
-223,800
219,500
305,800
Net Change In Cash
1,049,300
1,120,900
1,792,700
1,555,400
Cost of Revenue
65,800
-44,900
454,500
Free Cash Flow
-257,900
-149,900
96,100
395,000
Cash
111,700
642,600
576,100
621,300
Basic Shares
51,200
50,100
54,100
53,800

Earnings Calls

Quarter EPS
2024-09-30
$1.37
2024-06-30
-$2.32
2024-03-31
$0.59
2023-12-31
-$0.77